Welcome to our dedicated page for COMPOSECURE SEC filings (Ticker: CMPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GPGI, Inc. filings document the renamed public company formerly known as CompoSecure, Inc. and its Class A common stock listed on the NYSE under GPGI. The record includes Form 8-K reports for operating results, investor presentations, cash dividends, executive and segment leadership changes, and Regulation FD communications.
Proxy statements describe shareholder voting, board governance, executive compensation and corporate-governance proposals. Registration and prospectus-supplement filings cover resale shares held by selling stockholders, while material-event reports and exhibits document capital structure, legal opinions, securities registration matters and other disclosure obligations for the GPGI platform and CompoSecure business.
Form 4 highlights — CompoSecure, Inc. (CMPO)
- Reporting person: Director Kevin M. Moriarty
- Transaction date: 07/29/2025
- Security: Stock option granting the right to purchase 6,998 Class A shares
- Exercise price: $13.80 per share
- Vesting: 25 % on 07/29/2026 and 25 % on each of the following three anniversaries (fully vested 07/29/2029)
- Expiration: 07/29/2035
- Consideration: Options issued in lieu of the $50,000 annual cash retainer under the Non-Employee Director Compensation Policy
- Ownership after grant: 6,998 derivative securities held directly
No open-market purchase or sale of shares occurred; the filing records a compensatory grant that modestly increases potential future dilution but strengthens management–shareholder alignment.
CompoSecure, Inc. (Nasdaq: CMPO) filed an 8-K dated 14 July 2025 disclosing two governance-related developments.
- Amended & Restated Waiver Agreement (Item 1.01): On 12 July 2025 the Company, Resolute Compo Holdings LLC and Tungsten 2024 LLC reaffirmed earlier waivers to (i) keep the Board size below the eleven-director level required by the September 2024 Governance Agreement and (ii) waive the Holder’s right to designate a sixth director. The waiver eases immediate governance requirements in order to accommodate new appointments.
- Board appointments (Item 5.02): Effective 12 July 2025 the Board named Rebecca Corbin Loree (CEO, Corbin Advisors) as a Class III director through the 2027 AGM and Kevin Moriarty (former CFO, Blue Yonder & Avnet) as a Class I director through the 2028 AGM. Corbin Loree joins the Compensation Committee; Moriarty joins the Audit Committee.
- Compensation: Each director will receive (a) a sign-on equity award of stock options valued at ≈ $200,000 and (b) a prorated portion of the $250,000 annual option grant, both vesting over four years, plus customary indemnification agreements.
- A press release announcing the appointments (Exhibit 99.1) and the A&R Waiver Agreement (Exhibit 10.1) are included.
No financial performance data, earnings guidance or transactions affecting capital structure were reported.